Birdwatch Archive

Birdwatch Note Rating

2023-08-26 10:18:14 UTC - NOT_HELPFUL

Rated by Participant: 64D0AF9F8EC6BFAB62220C92EC3AEFF2D755144971816D5C6D3815F216C4CC29
Participant Details

Original Note:

EBC-46 has shown efficacy to reduce cancer in animal studies only. Clinical trials have since commenced for skin, head and neck, and soft tissue cancers in humans. In 2020 the FDA approved an EBC-46–based medication Stelfonta, to treat mast cell cancer in dogs. https://news.stanford.edu/2022/10/03/breakthrough-production-acclaimed-cancer-treating-drug/

All Note Details

Original Tweet

All Information

  • noteId - 1695190002055970932
  • participantId -
  • raterParticipantId - 64D0AF9F8EC6BFAB62220C92EC3AEFF2D755144971816D5C6D3815F216C4CC29
  • createdAtMillis - 1693045094544
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - NOT_HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 0
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 1
  • notHelpfulSourcesMissingOrUnreliable - 1
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 1
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 1
  • notHelpfulArgumentativeOrBiased - 1
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 1
  • notHelpfulOpinionSpeculation - 1
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 169519000205597093264D0AF9F8EC6BFAB62220C92EC3AEFF2D755144971816D5C6D3815F216C4CC29